UX Researcher Jobs in Connecticut
Joulé
Ridgefield, CT
Experience with cell culture techniques and molecular biology techniques including but not limited to Western blot, qRT-PCR, ELISA, FACS, enzyme inhibition assays, viability assays, functional screening assays of biologics, 2D & 3D culture systems of primary mouse and/or human cells. Bachelor’s degree with three+ years of experience in related scientific discipline, preferably in the Biopharmaceutical/Biotech industry, or Master’s degree.
Joulé
Ridgefield, CT
RequirementsApply knowledge of basic theory and scientific principles of cardio-renal-metabolic diseases for conducting in vivo research; direct experience in rodent models of metabolic-associated steatohepatitis and liver fibrosis is desirable. Demonstrates technical ability to assist in the design and execution of non-routine experiments in the context of cardio-renal-metabolic in vivo models; conducts exploratory experiments with minimal supervision.
Joulé
Ridgefield, CT
Execute relevant cellular/molecule functional assays (ELISA, TaqMan qPCR, color-metric based assays etc.) and cell-based imaging with minimal supervision. Perform literature searches and extract relevant information from published protocols and implements them; demonstrate the ability to interpret outcome of experiments and to propose appropriate follow-up.
Joulé
Ridgefield, CT
Utilizes various biochemical, molecular, cellular, and functional techniques to develop and validate complex assays using mammalian cells, tissues, and recombinant proteins to interrogate biological pathways of interest and support emerging biological concepts. Scientist III:Master’s Degree from an accredited institution with three-plus (3+) years of experience in related scientific discipline, OR Bachelor’s Degree from an accredited institution with seven-plus (7+) years of experience in related scientific discipline or equivalent experience in related field.
Arvinas Inc.
New Haven, CT
The company is progressing multiple investigational drugs through clinical development programs, including vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-102, targeting LRRK2 for neurodegenerative disorders; and ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
Arvinas Inc.
New Haven, CT
In addition to its robust preclinical pipeline of PROTAC protein degraders against validated and “undruggable” targets, the company has three investigational clinical-stage programs currently enrolling: vepdegestrant for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-102 for the treatment of patients with neurodegenerative disorders, and ARV-393 for the treatment of patients with relapsed/refractory non-Hodgkin Lymphoma and potentially other lymphomas. Learning methods for assessing protein levels and expression in various bioassays from in vitro cultures including: MSD-based ELISA, qPCR (QuantStudio 6 platform), flow cytometry (BD Fortessa, DIVA, FlowJo), protein quantification via western blot (traditional and higher throughput Jess platform).
Arvinas Inc.
New Haven, CT
In addition to its robust preclinical pipeline of PROTAC protein degraders against validated and “undruggable” targets, the company has three investigational clinical-stage programs currently enrolling: vepdegestrant for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-102 for the treatment of patients with neurodegenerative disorders, and ARV-393 for the treatment of patients with relapsed/refractory non-Hodgkin Lymphoma and potentially other lymphomas. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
Arvinas Inc.
New Haven, CT
In addition to its robust preclinical pipeline of PROTAC protein degraders against validated and “undruggable” targets, the company has three investigational clinical-stage programs currently enrolling: vepdegestrant for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-102 for the treatment of patients with neurodegenerative disorders, and ARV-393 for the treatment of patients with relapsed/refractory non-Hodgkin Lymphoma and potentially other lymphomas. Arvinas uses its proprietary PROTAC Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
Arvinas Inc.
New Haven, CT
In addition to its robust preclinical pipeline of PROTAC protein degraders against validated and “undruggable” targets, the company has three investigational clinical-stage programs currently enrolling: vepdegestrant for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-102 for the treatment of patients with neurodegenerative disorders, and ARV-393 for the treatment of patients with relapsed/refractory non-Hodgkin Lymphoma and potentially other lymphomas. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
Spectraforce Technologies Inc
Ridgefield, CT
The successful candidate, with a demonstrated ability to work in a matrix environment, will work within the Translational Biology group to develop in vitro cellular models relevant to fibrotic diseases. Candidate will work in a highly collaborative group and will support research projects that aim deliver innovative drug concepts for clinical development.
Spectraforce Technologies Inc
Ridgefield, CT
As an integral member of the New Biologic Expression, Purification, and Characterization (NBEPC) group, specifically within the Purification team, your main responsibility will be to provide expertise and knowledge in the area of protein purification, specifically focusing on purification of monoclonal antibodies and antibody formats. Perform scientific experiments that contribute to core group/research goals and reflect expert knowledge in development of biological drugs and in the area of protein purification, CMC evaluation and protein biochemistry related to the development of biological drugs.
Spectraforce Technologies Inc
Ridgefield, CT
Develop LC/MS methods for characterizing critical reagents; Conduct LC/MS analysis of reagent samples; Instrument calibration and data management, Write analytical reports; Archive analytical results and reports in electronic notebooks; Perform general lab chore and maintenance (such as ordering reagents and supplies, instrument inventory, lab safety activities, etc.). The successful candidate must demonstrate the following: Strong laboratory skills with the ability to resolve and advise on technical issues of a moderate scope and develop new skills through on-the-job experiences.
Spectraforce Technologies Inc
$44.65 HOUR
Ridgefield, CT
Develop LC/MS methods for characterizing critical reagents; Conduct LC/MS analysis of reagent samples; Instrument calibration and data management, Write analytical reports; Archive analytical results and reports in electronic notebooks; Perform general lab chore and maintenance (such as ordering reagents and supplies, instrument inventory, lab safety activities, etc.). SPECTRA FORCE is built on a concept of “human connection,” defined by our branding attitude of NEWJOBPHORIA®, which is the excitement of bringing joy and freedom to the work lifestyle so our people and clients can reach their highest potential.
Empower
$183300 - $265800 YEAR
FAIRFIELD, CT
Manage the creative development process in partnership with the creative team leads and build a strong partnership with the internal agency team leaders who this leader will partner with to ensure excellence in creative product outcomes-these department leads include brand media specialists, social, video and traffic managers. As the Head of Creative for Empower Personal Wealth, you will operate as an Executive Creative Director and oversee the creative development efforts for all the direct to consumer (D2C), performance marketing creative, UX design, rollover, cross-over, organic social media and participant communications for the enterprise.
Empower
$183300 - $265800 YEAR
HARTFORD, CT
Manage the creative development process in partnership with the creative team leads and build a strong partnership with the internal agency team leaders who this leader will partner with to ensure excellence in creative product outcomes-these department leads include brand media specialists, social, video and traffic managers. As the Head of Creative for Empower Personal Wealth, you will operate as an Executive Creative Director and oversee the creative development efforts for all the direct to consumer (D2C), performance marketing creative, UX design, rollover, cross-over, organic social media and participant communications for the enterprise.
Empower
$183300 - $265800 YEAR
MANCHESTER, CT
Manage the creative development process in partnership with the creative team leads and build a strong partnership with the internal agency team leaders who this leader will partner with to ensure excellence in creative product outcomes-these department leads include brand media specialists, social, video and traffic managers. As the Head of Creative for Empower Personal Wealth, you will operate as an Executive Creative Director and oversee the creative development efforts for all the direct to consumer (D2C), performance marketing creative, UX design, rollover, cross-over, organic social media and participant communications for the enterprise.
Empower
$183300 - $265800 YEAR
STAMFORD, CT
Manage the creative development process in partnership with the creative team leads and build a strong partnership with the internal agency team leaders who this leader will partner with to ensure excellence in creative product outcomes-these department leads include brand media specialists, social, video and traffic managers. As the Head of Creative for Empower Personal Wealth, you will operate as an Executive Creative Director and oversee the creative development efforts for all the direct to consumer (D2C), performance marketing creative, UX design, rollover, cross-over, organic social media and participant communications for the enterprise.
Empower
$183300 - $265800 YEAR
MERIDEN, CT
Manage the creative development process in partnership with the creative team leads and build a strong partnership with the internal agency team leaders who this leader will partner with to ensure excellence in creative product outcomes-these department leads include brand media specialists, social, video and traffic managers. As the Head of Creative for Empower Personal Wealth, you will operate as an Executive Creative Director and oversee the creative development efforts for all the direct to consumer (D2C), performance marketing creative, UX design, rollover, cross-over, organic social media and participant communications for the enterprise.